Bal Pharma Limited (BALPHARMA) — Working Capital to Net Assets Ratio
Bal Pharma Limited (BALPHARMA) has a Working Capital to Net Assets ratio of 15.8% as of March 2026. Working capital of Rs130.06 Million (current assets of Rs2.62 Billion minus current liabilities of Rs2.49 Billion) is measured against net assets of Rs822.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Bal Pharma Limited to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bal Pharma Limited Working Capital to Net Assets (2006–2026)
This chart shows how Bal Pharma Limited's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the ratio stands at 15.8%, reflecting working capital of Rs130.06 Million against net assets of Rs822.52 Million INR. See operational self-sufficiency of Bal Pharma Limited to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Bal Pharma Limited (2006–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bal Pharma Limited from 2006 to 2026, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Bal Pharma Limited.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 15.8% | Rs130.06 Million | Rs822.52 Million | Rs2.62 Billion | Rs2.49 Billion | ▼ -4.0 pp |
| 2025 | 19.9% | Rs153.72 Million | Rs774.04 Million | Rs2.35 Billion | Rs2.20 Billion | ▼ -25.0 pp |
| 2024 | 44.9% | Rs311.04 Million | Rs692.61 Million | Rs2.34 Billion | Rs2.03 Billion | ▲ +15.4 pp |
| 2023 | 29.5% | Rs188.22 Million | Rs637.02 Million | Rs2.28 Billion | Rs2.09 Billion | ▼ -2.8 pp |
| 2022 | 32.4% | Rs189.26 Million | Rs584.92 Million | Rs1.85 Billion | Rs1.66 Billion | ▲ +10.6 pp |
| 2021 | 21.8% | Rs116.14 Million | Rs533.54 Million | Rs1.64 Billion | Rs1.53 Billion | ▲ +18.2 pp |
| 2020 | 3.6% | Rs16.38 Million | Rs453.38 Million | Rs1.61 Billion | Rs1.59 Billion | ▼ -27.4 pp |
| 2019 | 31.0% | Rs186.69 Million | Rs602.21 Million | Rs1.82 Billion | Rs1.63 Billion | ▼ -20.1 pp |
| 2018 | 51.1% | Rs307.35 Million | Rs602.01 Million | Rs1.76 Billion | Rs1.45 Billion | ▼ -15.5 pp |
| 2017 | 66.5% | Rs399.37 Million | Rs600.31 Million | Rs1.61 Billion | Rs1.21 Billion | ▲ +8.4 pp |
| 2016 | 58.1% | Rs318.06 Million | Rs547.22 Million | Rs1.43 Billion | Rs1.11 Billion | ▲ +35.0 pp |
| 2015 | 23.1% | Rs127.66 Million | Rs551.68 Million | Rs1.05 Billion | Rs923.58 Million | ▲ +6.5 pp |
| 2014 | 16.7% | Rs83.45 Million | Rs500.50 Million | Rs951.17 Million | Rs867.72 Million | ▲ +15.4 pp |
| 2013 | 1.2% | Rs5.48 Million | Rs446.18 Million | Rs932.14 Million | Rs926.66 Million | ▲ +5.8 pp |
| 2012 | -4.5% | Rs-18.21 Million | Rs400.56 Million | Rs844.97 Million | Rs863.18 Million | ▼ -132.6 pp |
| 2011 | 128.0% | Rs463.12 Million | Rs361.75 Million | Rs809.00 Million | Rs345.88 Million | ▲ +12.2 pp |
| 2010 | 115.8% | Rs414.20 Million | Rs357.62 Million | Rs692.04 Million | Rs277.84 Million | ▲ +35.5 pp |
| 2009 | 80.3% | Rs299.08 Million | Rs372.35 Million | Rs612.54 Million | Rs313.46 Million | ▼ -18.4 pp |
| 2008 | 98.8% | Rs346.01 Million | Rs350.32 Million | Rs582.65 Million | Rs236.64 Million | ▲ +48.7 pp |
| 2007 | 50.1% | Rs167.21 Million | Rs334.02 Million | Rs548.08 Million | Rs380.87 Million | ▼ -5.3 pp |
| 2006 | 55.3% | Rs178.73 Million | Rs323.02 Million | Rs589.65 Million | Rs410.91 Million | — |